Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein;Inzidenz des malignen Melanoms und Veränderung der stadienspezifischen Inzidenz nach Einführung eines Hautkrebsscreenings in Schleswig-Holstein

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 57, Issue 1, 2014, Pages 77-83

  Eisemann, N ^a   Waldmann, A ^a   Katalinic, A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Early detection; Malignant melanoma; Screening; Skin cancer; Tumor stage

Indexed keywords

ADULT; AGED; CANCER STAGING; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84891679527     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-013-1876-1     Document Type: Article

References (32)

1. Eisemann N, Jansen L, Holleczek B et al (2012) Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol 167:606-612
2. Lowe JB, Ball J, Lynch BM et al (2004) Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot Int 19:437-444
3. Aitken JF, Elwood JM, Lowe JB et al (2002) A randomised trial of population screening for melanoma. J Med Screen 9:33-37
4. Goldberg MS, Doucette JT, Lim HW et al (2007) Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol 57:60-66
5. Leest RJ van der, Vries E de, Bulliard JL et al (2011) The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol Venereol 25:1455-1465
6. Breitbart EW, Waldmann A, Nolte S et al (2012) Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 66:201-211
7. Katalinic A, Waldmann A, Weinstock MA et al (2012) Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 118:5395-5402
8. Waldmann A, Nolte S, Weinstock MA et al (2012) Skin cancer screening participation and impact on melanoma incidence in Germany - an observational study on incidence trends in regions with and without population-based screening. Br J Cancer 106:970-974
9. Waldmann A, Nolte S, Geller AC et al (2012) Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360288 whole-body examinations. Arch Dermatol 148:903-910
10. Deutscher Bundestag (2013) Gesetz zur Weiterentwicklung der Krebsfrüherkennung und zur Qualitätssicherung durch klinische Krebsregister (Krebsfrüherkennungs- und -registergesetz - KFRG). 17/12221
11. Katalinic A, Holzmann M, Bartel C et al (2002) Appendix zum Jahresbericht 2001: Aktualisierte Daten von "Krebs in Schleswig-Holstein - Bd 1". Schmidt-Römhild, Lübeck
12. Wittekind C, Meyer H-J, Bootz F (1997) TNM-Klassifikation maligner Tumoren. Springer, Berlin
13. Wittekind C, Meyer H-J, Bootz F (2002) TNM Klassifikation maligner Tumoren. Springer, Berlin
14. Eisemann N, Waldmann A, Katalinic A (2011) Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol 11:129
15. Dobson AJ, Kuulasmaa K, Eberle E et al (1991) Confidence intervals for weighted sums of Poisson parameters. Stat Med 10:457-462
16. R Development Core Team (2011) R: a language and environment for statistical computing. In: R Foundation for Statistical Computing, Vienna, Austria
17. Esserman L, Shieh Y, Thompson I (2009) Rethinking screening for breast cancer and prostate cancer. JAMA 302:1685-1692
18. Anttila A, Sarkeala T, Hakulinen T et al (2008) Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health 8:38
19. Canfell K, Sitas F, Beral V (2006) Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust 185:482-486
20. Hofvind S, Sorum R, Thoresen S (2008) Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol 47:225-231
21. Pollan M, Michelena MJ, Ardanaz E et al (2010) Breast cancer incidence in Spain before, during and after the implementation of screening programmes. Ann Oncol 21(Suppl 3):iii97-iii102
22. Pollan M, Pastor-Barriuso R, Ardanaz E et al (2009) Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst 101:1584-1591
23. Aa MA van der, Pukkala E, Coebergh JW et al (2008) Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer 122:1854-1858
24. Liu F, Bessonova L, Taylor TH et al (2013) A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important. Pigment Cell Melanoma Res 26:128-135
25. Berwick M, Begg CB, Fine JA et al (1996) Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 88:17-23
26. Aitken JF, Elwood M, Baade PD et al (2010) Clinical whole-body skin examination reduces the incidence of thick melanomas. Int J Cancer 126:450-458
27. Geller AC, Swetter SM, Brooks K et al (2007) Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol 57:555-572 (quiz 573-556)
28. Levell NJ, Beattie CC, Shuster S et al (2009) Melanoma epidemic: a midsummer night's dream? Br J Dermatol 161:630-634
29. CRC Melanoma Pathology Panel (1997) A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. J Clin Pathol 50:202-205
30. Deutsche Dermatologische Gesellschaft (1998) Malignes Melanom. http://www.derma.de/de/daten/leitlinien/leitlinien/malignes-melanom. Zugegriffen: 29. November 2013
31. Gotzsche PC, Jorgensen KJ (2013) Screening for breast cancer with mammography. Cochrane Database Syst Rev 6:CD001877
32. Schoffer O, Niedostatek A, Werner C et al (2013) Dokumentation von Daten zum malignen Melanom in klinischen Krebsregistern deutschlandweit. In: 20. Informationstagung Tumordokumentation der klinischen und epidemiologischen Krebsregister. Lübeck